Skip to main content
. 2017 Nov 11;8(62):105819–105831. doi: 10.18632/oncotarget.22402

Figure 4.

Figure 4

(A) OPLS-DA scatter plot based on EC, HC, and stage-I/II CRC samples. (B) Statistical validation of the corresponding OPLS-DA model by permutation analysis (200 times).